Repository
How to publish
Resources
FAQs

MAPK inhibition and growth hormone: a promising therapy in XLH

Author:
Fuente Pérez, RocíoUniovi authority; Gil Peña, HelenaUniovi authority; Claramunt Taberner, DeboraUniovi authority; Hernández Frías, Olaya; Fernández Iglesias, Ángela; Alonso Durán, LauraUniovi authority; Rodríguez Rubio, Enrique; Hermida Prado, Francisco JoséUniovi authority; Anes González, Gonzalo; Rubio Aliaga, Isabel; Wagner, C.; Santos Rodríguez, FernandoUniovi authority
Publication date:
2019
Publisher version:
http://dx.doi.org/10.1096/fj.201802007R
Citación:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(7), p. 8349-8362 (2019); doi:10.1096/fj.201802007R
Descripción física:
p. 8349-8362
URI:
http://hdl.handle.net/10651/53135
ISSN:
1530-6860
DOI:
10.1096/fj.201802007R
Patrocinado por:

This study was supported by Fundación Nutrición y Crecimiento, Grants PI12/00987 (National Plan I + D + I2008–2011), PI15/02122 (Plan Estatal I + D + I 2013–2016), and PI18/01757 (Plan Estatal I + D + I 2017–2020) from the Instituto de Salud Carlos III (Madrid, Spain), and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare no conflicts of interest.

Id. Proyecto:

ISCIII/FEDER/PI12/00987

ISCIII/FEDER/PI15/02122

ISCIII/FEDER/PI18/01757

Collections
Files in this item
Compartir
Estadísticas de uso
Estadísticas de uso
Metadata
Show full item record